Ouch! Two UK Analgesic Ad Complaints: Reckitt Rapped, Perrigo Pardoned
Two UK advertising complaint verdicts delivered by the MHRA, Reckitt Benckiser's Nurofen Express (upheld) and Perrigo's Solpadeine Max (not upheld).
You may also be interested in...
Perrigo has found itself in hot water with the UK's MHRA over claims made on the website of its Solpadeine pain-relief brand. Meanwhile, the company has been exonerated after complaints against a TV ad to promote its XLS weight-loss brand proved to be unfounded.
By the positioning of a pack shot of its eponymous glucose supplement in a recent advertisement, Dextro Energy had implied the product could deliver an instant energy boost - which it was not authorized to do, ruled UK watchdog ASA.
The UK's Advertising Standards Authority has cleared Reckitt Benckiser of misleading British consumers with two advertisements for its Nurofen brand of analgesics.